Publications

Title

Author

Year

Bluetongue vaccines.

Noad, R; ROY, P;

2009

Vaccine, (2009).27 Sup SUPPL. 10.1016/j.vaccine.2009.08.037.

Cost-effectiveness of rotavirus vaccination in peru.

CLARK, AD; Walker, DG; Mosqueira, NR; Penny, ME; Lanata, CF; Fox-Rushby, J; SANDERSON, CF B;

2009

The Journal of infectious diseases, (2009).200 Su s1 10.1086/605043.

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.

Cheung, Y-B; ZAMAN, SM A; Nsekpong, ED; Van Beneden, CA; Adegbola, RA; GREENWOOD, B; CUTTS, FT;

2009

The Pediatric infectious disease journal, (2009).28 11 10.1097/INF.0b013e3181a78185.

Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.

Stewart, M; Bhatia, Y; Athmaran, TN; Noad, R; Gastaldi, C; Dubois, E; Russo, P; Thiéry, R; Sailleau, C; Bréard, E; Zientara, S; ROY, P;

2009

Vaccine, (2009).28 17 10.1016/j.vaccine.2009.10.072.

Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance.

Nokes, DJ; Ngama, M; Bett, A; Abwao, J; Munywoki, P; English, M; SCOTT, JA G; Cane, PA; MEDLEY, GF;

2009

Clinical infectious diseases, (2009).49 9 10.1086/606055.

Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.

Sirima, SB; Tiono, AB; Ouédraogo, A; Diarra, A; Ouédraogo, AL; Yaro, JB; Ouédraogo, E; Gansané, A; Bougouma, EC; Konaté, AT; Kaboré, Y; Traoré, A; Chilengi, R; Soulama, I; Luty, AJ F; Druilhe, P; COUSENS, S; Nébié, I;

2009

PloS one, (2009).4 10 10.1371/journal.pone.0007549.

An assessment of methods for routine local monitoring of vaccine efficacy, with particular reference to measles and pertussis.

Clarkson, JA; FINE, PE;

2009

Epidemiology and infection, (2009).99 2 10.1017/s0950268800067996.

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe.

JIT, M; Bilcke, J; Mangen, M-JJ; Salo, H; Melliez, H; EDMUNDS, WJ; Yazdan, Y; Beutels, P;

2009

Vaccine, (2009).27 44 10.1016/j.vaccine.2009.08.030.

Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.

Delany-Moretlwe, S; Jentsch, U; WEISS, H; Moyes, J; Ashley-Morrow, R; Stevens, W; MAYAUD, P;

2009

Sexually transmitted infections, (2009).86 1 10.1136/sti.2009.036541.

Toward a Malaria Vaccine The Elusive Malaria Vaccine Miracle or Mirage? by Irwin W. Sherman ASM Press, Washington, DC, 2009. 401 pp. $39.95. ISBN 9781555815158.

GREENWOOD, B;

2009

Science, (2009).326 5951 10.1126/science.1180581.